Introduction
Epithelial-to-Mesenchymal Transition (EMT) is a cellular transdifferentiation program, whereby cells lose their epithelial attributes and assume features of the mesenchymal lineage, along with elongated morphology, increased motility, reduced proliferation rate and expression of marker proteins, such as vimentin. This process occurs normally at certain stages of embryonal development, but is also reinstated during cancer progression, where it signifies acquisition of increased invasiveness and tumor cell stemness [1] [2] [3] .
Mesenchymal phenotype can be induced in epithelial cancer cells by several stimuli, including activation of certain proto-oncogenes (Ras) and growth factor receptor pathways, such as those driven by transforming growth factor beta (TGFα), hepatocyte growth factor (HGF) receptor (MET), or epidermal growth factor receptor (EGFR). This change may also result from environmental cues, including hypoxia, or occur as a result of other influences that can change the activity of EMT-regulating transcription factors, such as Twist, YB-1, Snail, Brachyury and several others [1, 4, 5] .
One of the consistent hallmarks of EMT is the disruption of adherens intercellular junctions, which liberates the cells from spatial and signaling constraints, and may enable their greater motility. This process is often linked with downregulation of E-cadherin [1] , which is a part of multimolecular hubs that modulate the activity of growth factor pathways, including EGFR [6] . Notably, disruption of E-cadherin-mediated adhesion by RNA interference [7] , or usage of specific neutralizing antibodies [8] has been reported to induce EMT-like features in epithelial cancer cells.
We have previously described an EMT-like phenotype associated with human squamous cell carcinoma cells (SCC) in vivo, and in xenografts of the well characterized SCC-derived cell line, A431, which is driven by the amplification of the epidermal growth factor receptor (EGFR) [9] . Interestingly, these cells exhibit epithelial morphology in culture, but can be induced to undergo EMT-like changes in the presence of the E-cadherin neutralizing antibody (SHE78-7) and EGFR activating ligands, such as transforming growth factor alpha (TGFα) [8, 9] . Under these conditions intercellular junctions become dissociated, and the cells assume elongated morphology, express vimentin and change their intracellular distribution of several proteins, including β-catenin [9] . This transition is also associated with an increased proficiency at forming metastatic nodules in lungs, and an exaggerated proangiogenic and procoagulant phenotype, at least in part due to upregulation of tissue factor (TF) on the tumor cell surface [8, 9] . Thus, EMT appears to alter not only intrinsic cellular properties of cancer cells, but also their ability to interact with the vascular system and their tissue surroundings in ways that are not fully understood.
Indeed, one of the most intriguing features associated with EMT, including in the case of A431 cells, is the change in the cellular secretome, especially as it relates to the emission profile of extracellular vesicles (EVs) [8] [9] [10] [11] . EVs are membrane structures that various cells shed into their microenvironment, either constitutively, or as a result of stress, activation, or oncogenic transformation [12] [13] [14] . There is a growing body of evidence to suggest that the uptake of cancer-related EVs by various types of recipient cell impacts their properties and behavior, and these influences have been implicated in such processes as angiogenesis, metastasis, immunoregulation, activation of the coagulation system, intercellular transfer of oncogenes and several other events [14] [15] [16] [17] [18] [19] [20] [21] [22] .
The various biological activities and molecular composition of EVs depend on mechanisms of their biogenesis (vesiculation), of which there are at least two main pathways. Thus, EVs may be formed due to plasma membrane blebbing, which results in formation of larger vesicles known as ectosomes or microvesicles (100-1000 nm in diameter). Smaller EVs (30-100 nm), known as exosomes, can be generated by the endosomal pathway, and they exhibit distinct molecular and physical properties, as well as cellular functions [23] . For example, exosomes have been implicated in the regulation of cell adhesion [24] , pericellular proteolysis [25] , removal of superfluous molecules from differentiating cells [26] , attenuation and modulation of intracellular signaling cascades [9, [27] [28] [29] and formation of regulatory gradients of morphogens, such as Wnt [30] .
Interestingly, vesiculation is known to lead to selective enrichment of some bioactive molecules but not others in the EV cargo, and the nature, mechanisms and consequences of these combinatorial processes encompassing large numbers of molecular species are still poorly understood [21, 31, 32] .
In this regard the nexus between EMT and the resulting changes in cellular vesiculation profiles has been explored by only a handful of recent studies [9] [10] [11] . For example, we have recently reported quantitative changes in the vesiculation pattern of mesenchymal A431 cells, with the prominent emission of procoagulant exosomes [9] . In the present study we asked whether these changes affect the qualitative and quantitative properties of tumor-related EVs, in particular, whether they alter the composition of the vesicular proteome. Indeed, we found that, as A431 cells transit between epithelial and mesenchymal states, the protein cargo of their derived EV undergoes a profound rearrangement. This shift was neither an exact replica of underlying changes within the proteome of EV-producing cells, nor a simple summation of the individual effects of EMT-inducers, such as the E-cadherin blocking antibody and EGFR agonists. Rather, at least 30 EV-associated protein changes were unique to the mesenchymal phenotype of their producing cells. In addition, the pathway analysis of the EV-related proteome revealed that mesenchymal transition predominantly affected proteins involved in proliferation, communication, junction formation, ECM adhesion and vesiculation itself, which is consistent with the nature of the underlying biological processes. We postulate that the composition of EVs may, in principle, serve as a biomarker of processes involved in cancer cell transdifferentiation, and may also define the biological role and activity of EVs in these settings.
Material and methods

Cell culture and treatments
The human squamous cell carcinoma (SCC) A431 cell line was obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured in DMEM (Life Technologies, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS)(Multicell Wisent Inc., St-Bruno, QC, Canada) depleted of EVs. Cells were serum-starved overnight, prior to treatments with 50 ng/mL of TGFα (Life Technologies), 2 μg/mL SHE78-7 anti-E-cadherin neutralizing antibody (Life Technologies) for 48 h.
Preparation of extracellular vesicles
EVs were obtained by ultracentrifugation as described earlier [9, 14, 33, 34] . Briefly, culture supernatants were centrifuged for 10 min at 400 g, followed by 2 h at 100,000 g to pellet EVs, which were washed extensively in phosphate buffered saline (PBS).
Western blotting
As described earlier [35] , membranes were prepared and probed with the following primary antibodies: rabbit anti-integrin α2 (Abcam, Toronto, ON, Canada), rabbit anti-human γ-catenin (Abcam), mouse anti-CD9 (Santa Cruz Biotechnology, Dallas, TX, USA), mouse anti-Flotillin-1 (BD Biosciences, Mississauga, ON, Canada), rabbit anti-GAPDH (Abcam), mouse anti-β-actin (Sigma Chemical Co., St Louis, MO, USA). Horseradish peroxidase (HRP)-conjugated secondary antibodies (Dako, Mississauga, ON, Canada) and chemiluminescence (GE Healthcare, Piscataway, NJ, USA) were used for detection.
Immunofluorescence
Cultured cells were fixed for 10 min in 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and stained overnight at 4 1C with rabbit anti-human Integrin-a2 (Abcam) rabbit antihuman γ-catenin (Abcam), or FITC-phalloidin (Sigma) followed by their respective secondary Alexa Fluor antibodies (Invitrogen).
Fluorescence-activated cell sorting
Single-cell suspensions were washed with phosphate-buffered saline containing 1% bovine serum albumin and 0.1% sodium azide before staining with FITC conjugated mouse anti-human CD44 and anti-human CD24 antibodies (BD Biosciences).
Cell and EV lysis and protein extraction
The cells were incubated in hypotonic lysis buffer containing 10 mM HEPES, pH 7.4 for 30 min on ice. The suspension was briefly sonicated and Triton-X-100 was added to a final concentration of 1.5%. The suspension was incubated at 4 1C for 30 min, followed by centrifugation at 14,000 rpm for 30 min at 4 1C. The supernatant was removed and used for proteomic analysis as previously described [36] . EVs were solubilised by incubation in 50 mM ammonium bicarbonate 0.2% PPS detergent for 60 min at 37 1C, followed by digestion with trypsin as described below.
In-solution protein digestion
An aliquot of 150 mg of protein from each cell lysate sample was precipitated overnight at À20 1C with 5-volumes of ice-cold acetone, followed by centrifugation at 21,000 g for 15 min. The protein pellet was solubilized in 8 M urea, 2 mM DTT, 50 mM Tris-HCl, pH 8.5 at 37 1C for 1 h, followed by carboxyamidomethylation with 10 mM iodoacetamide for 1 h at 37 1C in the dark. The samples were then diluted with 50 mM ammonium bicarbonate, pH 8.5 to $ 1.5 M urea. Calcium chloride was added to a final concentration of 1 mM and digested with a 1:25 M ratio of recombinant, proteomics grade trypsin (Roche Diagnostics, Laval, QC) at 37 1C overnight. The resulting peptide mixtures were solid phase-extracted with Varian OMIX cartridges (Mississauga, ON, Canada) according to the manufacturer's instructions and stored at À80 1C until further use.
Mass spectrometry (MS)
The samples were lysed and peptide mixtures were solid phaseextracted with Varian OMIX cartridges (Mississauga, ON, Canada). For analysis and protein identification, a fully automated 4-cycle, 8-h MudPIT procedure was set up similar as previously described [38] using a LTQ linear ion-trap (Fisher Scientific, Toronto, ON, Canada). Each sample was analyzed in duplicates. Raw files were converted to m/zXML using ReAdW and searched by a locally installed version of X!Tandem against a human UniProt protein sequence database as recently described [37] . To estimate and minimize our false positive rate the protein sequence database also contained protein sequence in its reversed amino acid orientation (target-decoy strategy). Search parameters were: Parent ion Δ-mass of 4 Da, fragment mass error of 0.4 Da, and oxidation of methionine as a variable modification and IAA modification of cystein as a static modification (only for lysate fraction). A rigorous peptide quality control strategy was applied to effectively minimize false positive identifications, as previously described (Taylor et al., 2009b) [FDRo1%]. To minimize protein inference we developed a database grouping scheme, and only report proteins with substantial peptide information, as recently reported [36] . Classification of proteins according to cellular pathways was performed with Ingenuity pathway analysis (IPA) software (Ingenuity Systems Inc., Redwood City, CA, USA). The experiments consisted of three runs, one pilot set and two full size sample sets the latter comprising all experimental conditions, in which untreated cells and cells treated with single agent served as reference, and these runs were manually spot checked for consistency with the pilot. To develop the protein profile associated with these treatments a cumulative approach was undertaken to overcome the impact of potential random sample-to-sample variability, which may result in missed signal for individual proteins. To accomplish this, both repeat samples from two independent experiments were combined and analyzed, as per shotgun approaches described earlier by us and others [38, 39] .
Results
EVs secreted by A431 cells contain proteins of different subcellular origins and functions
We have previously documented the ability of EGFR-driven human squamous cell carcinoma cells, A431, to emit extracellular vesicles of wide ranging sizes that can be visualized by electron microscopy and nanoparticle tracking (NTA). We have also shown that A431 cells undergo a mesenchymal change in phenotype, when exposed to the E-cadherin neutralizing monoclonal antibody (SHE78-7) and TGFα, a potent EGFR agonist, a process that alters their profile of vesiculation (as schematically shown in Fig. 1A ) [9] . This treatment induced a spinde shaped change in cell morphology, corresponding rearrangement in actin cytoskeleton (Fig. 1B and C) and provoked enrichment in the CD44-high/CD24-low immunophenotype (Fig. 1E-G) , which is attributed to the stem-like population of cancer cells often linked with EMT [2, 40] , including in the A431 cell line [41, 42] .
To understand the molecular underpinnings of EMT-related changes in A431 cell-derived EVs, we profiled their protein content using mass spectrometry (MS). Predictably, a large proportion of A431-derived EVs contained proteins annotated as either of membrane or cytoplasmic origin, with a sizeable and somewhat surprising contribution of nuclear signatures ( Fig. 2A) . Interestingly, marked differences were noted in the lists of the top 25 most abundant proteins identified in A431 EVs relative to the corresponding cell lysates (Table 1) , which is consistent with the notion of selective rather than random assembly of the EV cargo [21] .
We also used Gene Ontology (GO) classification to assess the global features of the EV proteome, of which a significant proportion was assigned to the metabolic process category (Fig. 2B) , with other prominent groupings involving binding (32%) or catalytic activity (30%) (Fig. 2B and C) . Amongst these proteins, 15% reveal a link to nucleic acid binding (Fig. 2D ). While these are not processes normally associated with the biology of EV, the GO databases are shaped by what is known in the literature about various cellular protein groupings, and this may not necessarily reflect the most germane functions some of these proteins may have in the context of EVs.
Manifestation of the mesenchymal phenotype in the EV proteome
We next monitored the transition of A431 cells toward the mesenchymal state upon incubation with the anti-E-cadherin antibody, SHE78-7, combined with stimulation of EGFR using TGFα [9] . While each of these treatments alone and their combination (SHE78-7/TGFα) exert dramatic effects on cellular behavior, the corresponding cellular proteomes retain a significant level of overlap (655 in total for cells) (Fig. 3A) . The overlap also exists between the respective EV fractions (366 proteins commonly detected for the 4 different conditions; Fig. 3B ).
However, subsets of proteins were also found to be relatively specific for either control EVs (83), or EVs produced by SHE78-7 treated cells (37), EVs emitted under TGFα treatment alone (12), or upon induction of EMT-like transition with both of these agents added simultaneously (30) , as depicted in Fig. 3B . Moreover our analysis of pathways represented by these EV-related protein sets (IPA) revealed a significant enrichment in proteins representative of cellular growth and proliferation, cell-to-cell signaling and interaction, cellular movement, and cell morphology pathways, especially upon transition to the mesenchymal state (SHE78-7/TGFα) as might be expected (Fig. 3D) .
It is of interest that the degree of change involving these protein clusters were far less pronounced in cells then in their derived EVs (Fig. 3C ). This may suggest that these proteins could exert their IPAassigned functions in some recipient cells, to which they could be transferred by EVs, as recently suggested by a number of reports [9, 10] . Alternatively, vesiculation may represent a mechanism to attenuate these particular protein functions by removing the respective molecular effectors from cells (or both) [9, 27] .
Changes in abundance and composition of proteins in cells and their EVs in the course of EMT
We observed that EMT process triggered changes in both relative abundance and qualitative composition of proteins detected by our MS screens. These changes differed between cells and their corresponding EVs. Indeed, some proteins were quantitatively depleted in the EV fraction (e.g. polypyrimidine tract binding protein 1), while others were enriched in EVs (e.g. myosin-1b), as a function of EMT induction. These patterns are captured in the heatmap (Fig. 4) , which lists proteins, for which there was more than 4 fold relative increase or decrease in spectral counts over the untreated controls (EVs or cells, respectively).
While the effects associated with the mesenchymal phenotype were of special interest, intriguing quantitative changes were also found in the case of treatment with TGFα or SHE78-7 alone (Fig. 4) . As mentioned earlier, not all proteins, for which a major change in levels was recorded, exhibited similar patterns of increase or decrease between A431 cells and their corresponding EVs, at least in selected settings. The examples of those include: SPTAN1 (spectrin alpha), ST13 (suppression of tumorigenicity 13/ HSP70 interacting protein) or HSD17B10 (17-β-Hydroxysteroid dehydrogenase X).
Mesenchymal phenotype is associated with enrichment of EVs in integrins and cell junction proteins
Out of 32 proteins upregulated in EVs following the SHE78-7/ TGFα treatment, by at least 2 fold (Table 2), 7 proteins (22%) were a part of the vesicle-mediated transport mechanism, according to PANTHER protein classification. Moreover, tetraspanin CD9 and Alix (PDCD6IP), which are exosomal markers [43] , were also enriched in EVs obtained from cells cultured under EMTinducing conditions, compared to control EVs (Table 2 ). This observation is congruent with the exosomal peak observed in our previous experiments using nanoparticle tracking analysis (NTA) to measure the emission of exosomes following EMTinducing treatments [9] .
When classified according to their GO Biological process annotation, more than half of these proteins were assigned to Cellular Process (GO:0009987), including 15 proteins related to cell communication (47%), 12 to cell adhesion (37%) and 6 proteins involved in cell motion (19%). When these data were filtered according to signaling pathways, the integrin signaling, clearly, appeared as a predominant feature, with 22% of the 32 upregulated proteins being included. This is consistent with changes underlying both EMT and vesiculation processes, both of which involve adhesive events and the presence of integrins [24] .
It is noteworthy that we were able to confirm a relatively selective integrin α2, γ-catenin and tetraspanin CD9 incorporation (Fig. 5A ). Whereas integrin α2 and γ-catenin are prominently expressed in cancer cells, we only detected a very low level of CD9 in cellular lysates. This was consistent with the proteomic analysis, for which no CD9 signal was detected in the cellular fractions, and the same was true for immunostaining experiments with anti-CD9 antibody (data not shown). Naturally, this does not reflect the absence of CD9 in cells, a source of CD9 in EVs, but rather the propensity of this particular tetraspanin to exit parental cells via the vesiculation pathway [27] . On the other hand, immunofluorescent stainings of integrin α2, and γ-catenin documented a change in localization of these two proteins following mesenchymal transition (Fig. 5BC) . Whereas under control conditions, both proteins were localized mainly at cellcell boundaries, in mesenchymal state these boundaries were dissolved and these two membrane-related proteins were more uniformly distributed throughout the cell surface, with some signal present intracellularly. The latter observation may suggest the presence of these proteins in precursory structures that give rise to exosomes (late endosomes) [9] . Thus, a direct western blot analysis confirms at least some of the changes detected in the EV proteome by mass spectrometry and points to selective enrichment of some proteins in the EV fraction, while others remain mostly cellular. We also further explored the functional connectivity between the respective protein clusters using the String 9.0 algorithm. In this regard, induction of the mesenchymal phenotype revealed EV protein groupings around such processes as vesiculation, cell junctions and cell-ECM interactions (Fig. 5D) . Overall, these results suggest that EMT-like changes induced in a controlled manner in a model of A431 cells lead to considerable and nonrandom rearrangements in the protein content of EVs these cells emit into their surroundings.
Discussion
While the ongoing profiling efforts resulted in the assembly of valuable databases of EV-related proteins (ExoCarta; Vesiclepedia) [44, 45] , the specific processes that may influence these profiles are only beginning to emerge. In this regard EMT is of particular interest as it reflects some of the most salient and intractable features of the malignant phenotype, including cellular stemness, tumor initiating ability, invasion and metastasis [1] [2] [3] 46] . This is also borne out in our findings, which suggest that mesenchymal A431 cells are more metastatic [8] and are enriched in the CD44-high/CD24-low phenotype, often regarded as a marker of epithelial cancer stem cells [2] .
For these reasons, questions as to the vesicular representations of these biological changes in the cancer microenvironment and in patient biofluids may be highly relevant. In fact, knowledge of EMT-signatures associated with EVs could lead to development of the respective biomarker platforms, while the molecular effectors contained in such EVs may also play important functional roles in specific cancers, and serve as new therapeutic targets [15, 47, 48] . Our study represents an early exploration of these possibilities, initially in a well-controlled and characterized cellular in vitro model of the mesenchymal transition in A431 cells.
In this regard it should be mentioned that several different pathways may lead to adoption of the operationally similar mesenchymal phenotype, by cells that are otherwise significantly different [1] . Therefore, while the changes we observed in the A431 model may be informative, they may not be universally applicable, and the related EV-associated EMT signatures should probably be sought in a more context-oriented manner, and with some consideration for the inducing mechanism. Thus, events acting upstream of E-cadherin may provoke EMT, either by general reprogramming of the cellular signaling network through oncogenic transformation e.g. upon expression of mutant Ras [11] , or by activation of EMT-inducing transcription factors, such as Twist, Snail or YB1 [49] , or by direct targeting of E-cadherin expression and function [2] , each with implicitly different molecular consequences. It is interesting to note, however, that amongst those diverse molecular changes the analysis of specific pathways may enable identification of common events, including in the cargo of related EVs (e.g. adhesion, motility). Indeed, our data support this suggestion.
The biological significance of changes in the EV cargo remains to be elucidated, and may be different for cells that emit EVs versus their surrounding cells, the latter potential EV recipients [9] . For example, we demonstrated earlier that A431 cells stimulated to undergo EMT-like changes become more metastatic [8] . In this regard, the role of EVs in metastasis is increasingly well documented [15, 20, 47, [50] [51] [52] . In a recent study Peinado et al. presented a compelling evidence that a part of this process involves transfer of the activated MET receptor from aggressive melanoma cells to bone marrow derived regulatory cells (BMDCs), the latter of which then control formation of pre-metastatic niches in distant organs [15] . Interestingly, MET is amongst the most potent effectors of EMT [1, 53] , the features of which have also been observed in melanoma [54] . Indeed, intercellular trafficking of MET during melanoma metastasis could exemplify wider linkages between processes of EMT and vesiculation. A431 cells are driven by EGFR and their expression and activity of MET is relatively low (data not shown). Therefore, the link between mesenchymal features, vesiculation and metastasis in this case is likely to entail an alternative mechanism. Indeed, activation of EGFR coupled with blockade of E-cadherin is sufficient to enforce mesenchymal transition in this cellular context. We have previously documented that these changes result in upregulation of the procoagulant receptor tissue factor (TF) and the onset of exaggerated procoagulant activity of both A431 cells and their EVs [9] . This is thought provoking, as the coagulation system plays a central role in metastasis [55, 56] , and the release of procoagulant EVs into the blood stream often correlates with disease outcomes [57] . While these are intriguing possibilities, EGFR or TF are not dominant proteins in the cargo of EVs emanating from mesenchymal A431 cells, which raises questions as to the identity, composition and putative functional potential of the wider EV proteome.
These questions motivated our present study, which documents several novel observations. Thus, we describe a link between epithelial-mesenchymal switching in the cancer cell phenotype and the composition of the related EV proteome. In this regard our Ingenuity analysis showed an increased number of proteins involved in EMT-linked pathways, that is: Cell-to-Cell Signaling and Interaction, Cellular Movement and Cell Morphology, in EVs emanating from mesenchymal A431 cells, as compared to controls. It is particularly striking that this difference was less pronounced in the cellular proteome than in the proteome of corresponding EVs (Fig. 2C and D) . The significance of this observation requires further scrutiny, but it is tempting to speculate that the EV-related proteome may act as a highly sensitive indicator of EMT in cancer cells.
Transition of A431 cells to the mesenchymal state correlates with enrichment of their EVs in exosomal markers CD9 and Alix (PDCD6IP), which are near the top of the list of upregulated proteins (Table 2) . This is consistent with our recent observation based on nanoparticle tracking analysis (NTA), which suggests that mesenchymal cells produce increased amounts of exosomesize particles [9] . This observation is important as changes may occur not only with regards to packaging proteins into a specific type of EVs, e.g. exosomes, but also in the composition of EVs being produced by a given cell. We observed that A431 release vesicular structures of markedly diverse sizes (Fig. 1) , and possibly with variable properties and biogenetic origin. How EMT may impact formation of exosomes, ectosomes and other forms of vesiculation remains presently unknown.
Proteome studies enable a wider assessment of molecular pathways that may converge upon certain biological phenotypes, functions or processes. This is important as the role of EVs in various tumor contexts is not identical [23] . For example, while other studies pointed to the presence of MET in the EV cargo, in our experiments a more prominent feature of EVs was a noticeable proportion of proteins involved in cell-ECM communication, especially proteins involved in integrin signaling. Similarly, results indicating the presence of integrin alphaIIb (CD41) in EVs were reported in the case of platelets, and linked to transfer of the metastatic phenotype to lung cancer cells [58] .
Our proteomic analysis also showed an increased release of proteases in the EV fraction of A431 cells treated with SHE78-7 and TGFα. These enzymes include ADAM10, (2.8 fold change) and MMP14 (2 fold). The significance of their vesicular release is presently unknown, but exosome related proteases were recently implicated in tumor cell invasion [25] . MMP-14 and integrin β1 have also been found in the exosomal fraction of human fibrosarcoma (HT-1080) and melanoma (G361) cells, both endowed with metastatic potential. Interestingly, transfer of these exosomes to recipient cells stimulated other MMP activities, potentially impacting a larger microenvironment [59] . More recently, Tauro et al. demonstrated, in the H-ras induced EMT model of MDCK cells, a similar increase in the presence of MMP-14, integrin β1 and integrin α3 [11] . Likewise, another study documented a crucial role of integrins during EMT induction by exposure of mammary epithelial cells to TGF β1, and this change was implicated in tumor invasiveness [60] . Interestingly, 5 integrins upregulated in this latter context were also found at increased levels in the cargo of EVs emitted by mesenchymal A431 cells in our study (Table 2 ).
An independent analysis of the A431 proteome conducted by Park et al. suggested the involvement of exosomal proteins in the metastatic potential of these cells, especially under hypoxic conditions [62] . EGFR and hypoxia have also been found to cooperate in induction of EMT in A431 cells [61] , an observation that may explain the focal presence of vimentin expressing cancer cells in A431 xenografts, and in human cancer samples, as we reported earlier [9] . It would be of interest to test whether EMT protein (and mRNA) signatures in circulating EVs may reflect the hypoxic nature of the underlying tumors. In line with this supposition, the protein profiles of hypoxic A431 cells published recently by Park et al., reveal similar classes of changes as those we observed in EVs upon EMT induction using TGFα and SHE78-7 antibody treatment, including emission of proteins linked to cellcell contact and cell-ECM adhesion [62] .
Thus, our study documents for the first time the scope of proteomic changes that are induced in EVs of epithelial cancer cells in the course of mesenchymal changes imposed in a manner dependent on the activity of EGFR and E-cadherin. We believe that these results add new perspective to the previous proteomic studies performed on EV fractions [63] [64] [65] , by demonstrating the molecular plasticity of the vesiculation process and its links to cellular differentiation and transformation. What remains to be determined is the functional consequence of the emission, retention and/or intercellular transfer of proteins we identified in the cargo of EVs. We can only infer this from the nature of the molecular composition of tumor-derived EVs, and more direct approaches are to follow. This question is especially relevant for processes such as metastasis, where both EMT and vesiculation play increasingly recognized roles [11] .
